Prostate cancer: biological dose considerations and constraints in tele- and brachytherapy

Strahlenther Onkol. 2007 Dec:183 Spec No 2:14-5. doi: 10.1007/s00066-007-2006-5.

Authors

Wolfgang Dörr¹, Jana Jaal, Daniel Zips

Affiliation

¹ Department of Radiotherapy and Radiation Oncology, Medical Faculty Carl Gustav Carus, University of Technology, Dresden, Germany. Wolfgang.Doerr@tu-dresden.de

PMID: 18166999
DOI: 10.1007/s00066-007-2006-5

No abstract available

MeSH terms

Brachytherapy* / adverse effects
Dose Fractionation, Radiation
Humans
Male
Prognosis
Prospective Studies
Prostate / pathology
Prostatic Neoplasms / diagnosis
Prostatic Neoplasms / pathology
Prostatic Neoplasms / radiotherapy*
Radiation Injuries / etiology
Radiotherapy Dosage
Radiotherapy, Conformal* / adverse effects
Radiotherapy, Intensity-Modulated
Randomized Controlled Trials as Topic
Rectum / radiation effects
Risk Factors
Time Factors
Urinary Bladder / radiation effects